Clinical Trials
4
Active:0
Completed:2
Trial Phases
3 Phases
Early Phase 1:1
Phase 1:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (50.0%)Early Phase 1
1 (25.0%)Not Applicable
1 (25.0%)Safety Study of Acellular Tissue Engineered Vessel for Coronary Artery Bypass
Not Applicable
- Conditions
- Coronary Artery DiseaseMulti Vessel Coronary Artery Disease
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Vascudyne, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT07078370
- Locations
- 🇵🇱
University Clinical Hospital No. 2 PUM in Szczecin, Szczecin, Poland
🇵🇱Medicover, Warszawa, Poland
Initial Evaluation of Vascudyne Coronary Artery Bypass Conduit
Early Phase 1
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2025-09-19
- Lead Sponsor
- Vascudyne, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT06434935
- Locations
- 🇵🇾
Sanatario Italiano, Asunción, Paraguay
Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)
Phase 1
Completed
- Conditions
- End Stage Renal Disease
- Interventions
- Biological: Arteriovenous conduit implant
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- Vascudyne, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT05567757
- Locations
- 🇵🇦
Centro de Asistencia Renal, Río Hato, Coclé, Panama
Preliminary Safety of The TRUE Vascular Graft for Hemodialysis Access (TRUE HD I Study)
Phase 1
Completed
- Conditions
- End Stage Renal Disease
- First Posted Date
- 2021-05-27
- Last Posted Date
- 2022-06-23
- Lead Sponsor
- Vascudyne, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT04905511
- Locations
- 🇵🇾
Sanatario Italiano, Asunción, Paraguay
News
No news found